Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Issued (2022 - 2025)

Praxis Precision Medicines has reported Shares Issued over the past 4 years, most recently at $11.6 million for Q4 2025.

  • Quarterly results put Shares Issued at $11.6 million for Q4 2025, up 488.25% from a year ago — trailing twelve months through Dec 2025 was $13.3 million (up 404.14% YoY), and the annual figure for FY2025 was $13.3 million, up 404.14%.
  • Shares Issued for Q4 2025 was $11.6 million at Praxis Precision Medicines, up from $808000.0 in the prior quarter.
  • Over the last five years, Shares Issued for PRAX hit a ceiling of $11.6 million in Q4 2025 and a floor of $1000.0 in Q3 2023.
  • Median Shares Issued over the past 4 years was $304500.0 (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Shares Issued: tumbled 99.76% in 2023 and later soared 20000.0% in 2024.
  • Praxis Precision Medicines' Shares Issued stood at $163000.0 in 2022, then tumbled by 34.97% to $106000.0 in 2023, then soared by 1762.26% to $2.0 million in 2024, then surged by 488.25% to $11.6 million in 2025.
  • The last three reported values for Shares Issued were $11.6 million (Q4 2025), $808000.0 (Q3 2025), and $294000.0 (Q2 2025) per Business Quant data.